Abstract | BACKGROUND: METHODS: Forty out-patients (29 males, 11 females, mean age: 59 years, range 40-70), with viral liver cirrhosis and chronic HE (1st-2nd degree) were studied. HE was assessed by considering: mental state, asterixis, number connection test (NCT), arterial blood ammonia levels. Patients were randomly assigned to the following treatments: rifaximin (plus sorbitol as placebo) (group R); lactitol (group L); rifaximin plus lactitol (group RL). All treatments were continued for 15 days for 3 cycles, intervalled by 15 days of washout. RESULTS: The 3 treatments reduced HE, but with different efficacy: patients of group R and RL significantly (p<0.05) documented a faster improvement in HE degree, a higher percentage of patients which normalized mental state and NCT, a faster improvement of asterixis and a longer persistence of normal ammonia levels than patients of group L. CONCLUSIONS:
|
Authors | C Loguercio, A Federico, V De Girolamo, A Ferrieri, C Del Vecchio Blanco |
Journal | Minerva gastroenterologica e dietologica
(Minerva Gastroenterol Dietol)
Vol. 49
Issue 1
Pg. 53-62
(Mar 2003)
ISSN: 1121-421X [Print] Italy |
PMID | 16481971
(Publication Type: Journal Article)
|